Nutra Pharma annual free cash flow
2010
2011
2012
2014
2015
2016
2017
2020
2021
2022
2025
Nutra Pharma Free Cash Flow (FCF) History (NPHC)
Nutra Pharma reported −$1.2M in free cash flow for fiscal 2025, a decrease of $369,591 from the previous fiscal year, with a free cash flow margin of −461.94%.
View full Nutra Pharma company overviewNutra Pharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$1.2M | −$369,591 | — | −461.94% |
| 2022 | 2022-12-31 | −$820,425 | $963,087 | — | −562.71% |
| 2021 | 2021-12-31 | −$1.8M | −$899,521 | — | −1824.84% |
| 2020 | 2020-12-31 | −$883,991 | $263,469 | — | −1703.36% |
| 2017 | 2017-12-31 | −$1.1M | $212,420 | — | −948.48% |
| 2016 | 2016-12-31 | −$1.4M | −$340,974 | — | −807.74% |
| 2015 | 2015-12-31 | −$1.0M | −$849,227 | — | −349.78% |
| 2014 | 2014-12-31 | −$169,679 | $551,563 | — | −28.54% |
| 2012 | 2012-12-31 | −$721,242 | $1.2M | — | −354.78% |
| 2011 | 2011-12-31 | −$1.9M | −$459,296 | — | −1183.89% |
| 2010 | 2010-12-31 | −$1.4M | — | — | −99.87% |
Nutra Pharma quarterly free cash flow
Q3.10
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.15
Q2.15
Q3.15
Q4.15
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$219,818 | −$165,786 | — | −761.56% |
| Q3 2025 | 2025-09-30 | −$250,770 | −$85,429 | — | −357.01% |
| Q2 2025 | 2025-06-30 | −$288,370 | −$3,545 | — | −341.14% |
| Q1 2025 | 2025-03-31 | −$431,058 | −$114,831 | — | −582.72% |
| Q4 2022 | 2022-12-31 | −$54,032 | $183,923 | — | −68.41% |
| Q3 2022 | 2022-09-30 | −$165,341 | $252,183 | — | −671.46% |
| Q2 2022 | 2022-06-30 | −$284,825 | $238,925 | — | −1001.81% |
| Q1 2022 | 2022-03-31 | −$316,227 | $288,056 | — | −2298.33% |
| Q4 2021 | 2021-12-31 | −$237,955 | −$47,573 | — | −915.67% |
| Q3 2021 | 2021-09-30 | −$417,524 | −$209,087 | — | −2167.15% |
| Q2 2021 | 2021-06-30 | −$523,750 | −$21,355 | — | −1719.52% |
| Q1 2021 | 2021-03-31 | −$604,283 | −$486,591 | — | −2743.87% |
| Q4 2015 | 2015-12-31 | −$190,382 | −$126,307 | — | −483.55% |
| Q3 2015 | 2015-09-30 | −$208,437 | −$56,740 | — | −394.25% |
| Q2 2015 | 2015-06-30 | −$502,395 | −$208,061 | — | −643.58% |
| Q1 2015 | 2015-03-31 | −$117,692 | −$40,563 | — | −97.27% |
| Q1 2013 | 2013-03-31 | −$64,075 | $134,007 | — | −284.07% |
| Q4 2012 | 2012-12-31 | −$151,697 | $736,750 | — | −95.51% |
| Q3 2012 | 2012-09-30 | −$294,334 | $88,557 | — | −2226.26% |
| Q2 2012 | 2012-06-30 | −$77,129 | — | — | −473.16% |
| Q1 2012 | 2012-03-31 | −$198,082 | — | — | −1326.38% |
| Q3 2011 | 2011-09-30 | −$888,447 | — | — | −352.80% |
| Q3 2010 | 2010-09-30 | −$382,891 | — | — | −106.38% |
Nutra Pharma free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$1.4M to −$1.2M, a net increase of $169,864. Nutra Pharma's latest reported quarter, Q4 2025, generated −$219,818 in free cash flow, a decrease of $165,786 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Nutra Pharma filings at SEC.gov ↗